Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation
Kazuyuki Murase(University of Fukui), Jerome Ritz(Dana-Farber Cancer Institute), E. Alyea(Harvard University), Anthony Letai(Dana-Farber Cancer Institute), Yutaka Kawano(Sapporo Medical University), Vincent T. Ho, Jeremy Ryan(Dana-Farber Cancer Institute), J. Koreth(Harvard University), Matthew S. Davids(Dana-Farber Cancer Institute), Carol G. Cutler(Harvard University), O. R. G. Bascug(Dana-Farber Cancer Institute), RJ Soiffer(Harvard University), Bruce R. Blazar(University of Minnesota Medical Center), Joseph H. Antin(Harvard University), H. T. Kim(Harvard University), Phillippe Armand(Harvard University), Ken‐ichi Matsuoka(Okayama University)
Cited by 20
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
|Journal of Clinical Oncology|2017|752